Jim Simons Neurocrine Biosciences Inc Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,366,397 shares of NBIX stock, worth $325 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
2,366,397
Previous 2,502,697
5.45%
Holding current value
$325 Million
Previous $277 Million
7.45%
% of portfolio
0.42%
Previous 0.44%
Shares
27 transactions
Others Institutions Holding NBIX
# of Institutions
660Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.95 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$766 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$614 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$424 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...